The Treatment Outcomes of Cesarean Scar Pregnancy

The Treatment Outcomes of Cesarean Scar Pregnancy:A Multicenter Prospective Randomized Controlled Study

A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.

Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

Study Type

Interventional

Enrollment (Estimated)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310006
        • Recruiting
        • Women's Hospital School of Medicine Zhejiang University
        • Contact:
        • Sub-Investigator:
          • Wanren Zheng, MD
        • Sub-Investigator:
          • Juan Yu, MD
        • Sub-Investigator:
          • Meijun Guo, MD
        • Sub-Investigator:
          • Ning Wang, MD
        • Sub-Investigator:
          • Shanshan Ni, MD
        • Sub-Investigator:
          • Xingmiao Li, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Women over 18 years old with a history of cesarean section
  2. Ultrasound diagnosis of cesarean scar pregnancy
  3. No severe internal or external diseases, such as liver disease, kidney disease, cardiovascular disease, cerebrovascular disease, etc., and able to tolerate surgery

Exclusion Criteria:

  1. Women under the age of 18
  2. CSP patients who have received treatment in other hospitals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: excisional surgery group
The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach.
The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
Experimental: conservative surgery group
Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
successful surgical treatment
Time Frame: One day after surgery
successful treatment rate after surgery
One day after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
complication
Time Frame: One day after surgery
severe complication rate after surgery
One day after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
subsequent pregnancy rate
Time Frame: Up to 24 months after surgery without contraception and the time since the last menstrual period is 4 weeks or more.
subsequent pregnancy rate after surgery
Up to 24 months after surgery without contraception and the time since the last menstrual period is 4 weeks or more.
CSP recurrence rate
Time Frame: Up to 24 months after surgery without contraception
CSP recurrence rate after surgery
Up to 24 months after surgery without contraception
pregnancy interval
Time Frame: Up to 24 months (the time interval between the cessation of contraception after surgery and the time of last menstrual period of the subsequent pregnancy)
pregnancy interval after surgery
Up to 24 months (the time interval between the cessation of contraception after surgery and the time of last menstrual period of the subsequent pregnancy)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: xiuxiu jiang, women's hospital school of medicine Zhejiang uni

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 13, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

August 12, 2025

First Submitted That Met QC Criteria

May 26, 2026

First Posted (Actual)

May 27, 2026

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 26, 2026

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • XiuxiuJiang

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Scar Pregnancy

Clinical Trials on different surgical treatment

Subscribe